版本:
中国

BRIEF-Spectral Medical submits fourth, final PMA module for Toraymyxin with U.S. FDA

May 30 Spectral Medical Inc:

* Spectral Medical- submitted fourth and final module of its PMA application to U.S. FDA based on further analysis of euphrates trial Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐